At Kura Oncology, They are committed to realizing the promise of precision medicines for cancer. The genomics revolution is transforming how they treat cancer. They now understand that how a patient responds to treatment depends in part on the genetic makeup of the cancer and, importantly, we have the knowledge and tools to create targeted treatments and companion diagnostics to identify those patients most likely to benefit. This new era offers the potential for innovative treatments that are safer and more effective for patients with particular cancers. They are leveraging our insights into cancer genetics as well as our core strength of translating novel science into life-saving medicines to advance a pipeline of precision medicines. Their development programs target cancers with high unmet need, including lung, colorectal, thyroid and pancreatic cancers as well as blood cancers such as lymphoma and leukemias.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Araxes Pharma LLC is an American private company located in La Jolla, CA. The firm develops drugs for the treatment of cancer and other diseases.

Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO.

Bayer Schering Pharma AG is a research-centered pharmaceutical company that was formed by the merger of Schering with Bayer on 29 December 2006. The company was originally founded in 1851 by Ernst Christian Friedrich Schering. The company employs more than 26,000 people in 140 subsidiaries all over the world. The company's headquarters are in Berlin-Wedding, Germany and the forerunner company Schering's annual gross revenue was nearly € 5 billion. They retain the largest German manufacturing facility which is located in Bergkamen. The company focuses on the business areas of gynaecology and andrology, oncology, and also special therapeutics, diagnostical devices, and nuclear medicine. Schering's best-known product is their line of combined oral contraceptive pills. Through Bayer Healthcare AG, Bayer Schering Pharma is a full member of the European Federation of Pharmaceutical Industries and Associations.

Our mission is to provide effective and patient centric treatment for hypertension- including resistant hypertension. In doing so creating a universal platform for the effective treatment of hypertension as well as for the distribution of fixed dose combination [FDC] hypertensive drugs such as Prestalia® and those in our pipeline. The company commercial product Prestalia® is approved by US FDA for the treatment of hypertension and being commercialized through the DyrctAxess platform. The company is also developing and commercializing late stage, non-addictive pain therapeutics. The company’s ‘next-generation of celecoxib,’ including IT-102 and IT-103, are designed to control the dangerous side-effect of edema that prohibits the drug from being prescribed at higher doses. These have the potential of replacing opioids and combatting the opioid epidemic.

Immunomedics is a biopharmaceutical company that specializes in developing monoclonal antibody-based products for the treatment of cancer and other serious diseases. Its corporate objective is to become a fully-integrated biopharmaceutical company. The company was founded in 1982 and headquartered in Morris Plains, New Jersey.

Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

Runan Medical Technology (Suzhou) Co., Ltd., established on 2020-03-13, Business scope includes licensed projects:Class III medical device business;Production of Class III Medical Devices;Production of Class II Medical Devices(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Biochemical product technology research and development;Research and development of bio-based materials technology;Wholesale of chemical products(Free of Hazardous Chemicals);Retailing of computer software, hardware and auxiliary equipment;Wholesale of computer software, hardware and auxiliary equipment;Wholesale of Class I Medical Devices;Retailing of Class I Medical Devices;Wholesale of Class II Medical Devices;Retailing of Class II Medical Devices;Wholesale of machinery and equipment;Instrument wholesale;General Equipment Repair;Wholesale of rubber products;Plastic Products Wholesale;software development;Health Consulting Services(Does not include medical services);Information Consulting Service(Not including licensing information consulting services);Socioeconomic Advisory Services;Conference and Exhibition Services;Production of Class I Medical Devices;Development of Human Gene Diagnosis and Therapy Technology(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Shanghai Runan Medical Technology Co., Ltd., established on 2019-04-29, Business scope includes general items:medical technology,Medical Technology,Biological Technology,medical instruments,Inspection technology,Technology development in the field of information technology,technology transfer,technical consulting,Technical Services;Chemical Products(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals),Biological reagents for non-clinical diagnosis,Sales of computer software, hardware and auxiliary equipment;Equipment,Instrumentation,electronic product,Sales of laboratory equipment,installation and maintenance;software development;business inquiries;Conference Services;Nutrition and Health Consulting Services;Biotechnology Extension Services;R&D of Class I medical devices,Sales;R&D of Class II Medical Devices,Sales;R&D of Class III Medical Devices.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license) licensed items:Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Zhenhe Precision Medicine Laboratory Wuxi Co., Ltd., established on 2017-04-10, The scope of business includes medical laboratory;Pathology;Medical Research;selling computers,Software and Auxiliary Equipment,electronic product,Electronic Component,communication equipment(Excluding radio and television ground receiving facilities and transmitters),laboratory equipment,medical instruments,Chemical Products(Free of Hazardous Chemicals);Self-operated and agent import and export business of various commodities and technologies,Except for commodities and technologies that are restricted by the state to be operated by enterprises or prohibited from import and export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Inspection and testing service;road freight transport(Does not contain dangerous goods);Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Sales of Class II Medical Devices(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Promega Contributing to the prevention, healing and more. Founded in 1978, which began with the production of enzymes for research, has evolved into a catalog of over 2,000 products for a wide range of applications, including basic research, drug discovery, forensics, paternity testing and diagnosis clinician.

The USC Incubator accelerates the development of USC’s top student and alumni entrepreneurs through experiential education, mentorship and community. The USC Incubator, supported by the Greif Center for Entrepreneurial Studies at USC’s Marshall School takes founders from feasibility and development work, on to customers, a tested business model, getting distribution, building a team, bootstrapping and investment preparation. They also provide access to other supporting resources, such as legal and financial assistance.

Shanghai Rigen Biotechnology Co. Ltd. is a company headquartered in China. The firm provides research and development services.

Van Andel Institute provides biomedical research and education services. Its services include antibody production, spectral karyotyping, immunostaining and mouse modeling, animal imaging, computational biology, flow cytometry, germline modification and cytogenetics, mass spectrometry and proteomics, microarray technology, sequencing, vivarium, xenotransplantation and michigan animal consortium, as well as analytical, cellular and molecular microscopy services. The company was founded by Jay van Andel and Betty Van Andel in 1996 and is headquartered in Grand Rapids, MI.

Yiling (Beijing) Biotechnology Co., Ltd., established on 2018-06-13, Business scope includes biotechnology promotion,Technical Services,technology transfer,technology development,technical consulting.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policy of the district.)

Beijing Sanpin Medical Technology Co., Ltd., established on 2011-09-23, Business scope includes technology promotion;Sales of Class I medical devices,Class II medical device;Maintenance of medical equipment;lease commercial premises,office(Shall not be used as premises for tangible market operations);Wholesale Medical Device Class III:6840Clinical laboratory analysis instruments and diagnostic reagents(Contains diagnostic reagents)(The medical device business license is valid until2023year08moon02day).(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policy of the district.)